Model Checkpoint Epoch: 3.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Low BF% is common in term infants and is associated with increased risk of neonatal morbidity. Future studies should consider using BF% as an outcome for neonatal nutritional screening. This may be more effective than using birth weight alone. Screening for undernutrition based on BF% may be more practical than measuring weight alone. Furthermore, identifying low BF% may help identify those neonates at greatest risk of long-term health problems. This information could aid targeted interventions to prevent short- and long-term sequelae of undernutrition. In addition, it may also help identify infants who have missed their growth curve and are at greater risk of subsequent health problems. To our knowledge, this is the first study to report the relationship between BF% and neonatal morbidity. However, this requires further investigation to establish its clinical utility. Copyright © 2016 John Wiley & Sons, Ltd.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.5
Reasoning:
The assistant's answer correctly notes that low BF% is associated with higher neonatal morbidity and that BF% could be more useful than birth weight alone for identifying undernourished neonates. However the reply is vague, omits the study's key comparative points and quantitative findings (e.g., odds ratios, prevalence of low BF%), and makes an incorrect or unsupported claim that BF%-based screening is "more practical" than measuring weight (BF% measurement by air displacement plethysmography is less practical for routine screening). It also repeats speculative conclusions without clearly stating the study's specific conclusion that BF% can identify appropriately grown but undernourished infants and exclude small infants not at risk. Overall the response is partially correct but incomplete and contains at least one misleading practicality claim.

conciseness: 0.3
Reasoning:
Explanation: The assistant's reply fails to concisely answer the question. It is repetitive, contains speculative and somewhat contradictory statements, does not give a clear direct yes/no conclusion, and includes irrelevant text (copyright). A concise, focused answer would state that BF% is more closely associated with neonatal morbidity than birth weight percentiles in this study and therefore may be a better measure of undernutrition, while noting the need for further validation.

relevance: 0.6
Reasoning:
Explanation: The assistant's reply answers the question by stating that low BF% is associated with increased neonatal morbidity and suggesting BF% may be superior to birth weight percentiles for screening — which aligns with the study's findings. However, it does not include or clearly cite a real quote from the provided context, adds speculative claims (e.g., "more practical than measuring weight alone," "first study") that are not supported by the excerpt, and includes an irrelevant copyright line. Overall relevant but imprecise and partially unsupported.

coherence: 0.4
Reasoning:
The response is only partially coherent. It conveys the main point (BF% may better identify at-risk neonates than birth weight) but is repetitive, makes unsupported or contradictory claims (e.g., stating BF% screening is "more practical than measuring weight alone" despite BF% measurement requiring specialized equipment), and includes irrelevant material (a copyright line). It does not give a clear, concise yes/no answer with justification from the study data and is lightly organized rather than tightly structured.

helpfulness: 0.3
Reasoning:
The assistant's reply is only partly helpful. It asserts that low BF% is associated with increased neonatal morbidity and that BF% may be a better screening measure than birth weight, which aligns generally with the study's conclusion, but it omits key supporting details (effect sizes, prevalence) and makes inaccurate or unsupported claims (for example, stating low BF% is "common in term infants" and that BF% screening "may be more practical than measuring weight alone" despite BF% requiring specialized equipment). It also repeats phrases, offers vague recommendations without acknowledging important limitations (sample size, setting, feasibility of air displacement plethysmography, need for validation), and includes an irrelevant copyright line. Overall the response is moderately relevant but incomplete and contains misleading statements, so its helpfulness and accuracy are limited.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: The treatment of ischemic Charcot foot seems to be different from other types of Charcot foot. This study shows that this treatment approach can give good results, especially when there is no infection or deep wound. Further studies on larger series will allow us to confirm these findings. We hope that this approach will help to change the current trend of treating ischemic Charcot foot with amputation. The success of the treatment depends on the correct diagnosis and early treatment. However, it is important to note that this type of Charcot foot is very rare. Therefore, it would be useful to perform a multicenter registry to improve our knowledge about its prevalence, etiology, pathophysiology and natural history. Furthermore, we suggest that more prospective trials should be performed to compare the outcome of the different treatments. In conclusion, the treatment of ischemic Charcot foot has been shown to be effective, and we believe that this approach will help to change the current trend of treating this condition with amputation. Finally, we think that further studies on larger series will allow us to confirm these findings and better define the indications for the use of this new approach. Copyright © 2013 ISMP. Published by Elsevier Ltd. All rights reserved.
[/INST]
The treatment of ischemic Charcot foot seems to be different from other types of Charcot foot. This study shows that this treatment approach can give good results, especially when there is no infection or deep wound. Further studies on larger series will allow us to confirm these findings and better define the indications for the use of this new approach. Future randomized studies should also be designed to confirm these results. The aim of future trials should be to establish the optimal treatment of ischemic Charcot foot. At present, the only evidence available suggests that the combination of endovascular revascularization, surgical debridement, and orthopedic correction is safe and effective. However, further studies should be carried out to confirm these results and to determine whether any advantage exists in using a specific type of treatment. This will help us to make the best decision possible regarding the treatment of ischemic Charcot foot.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.7
Reasoning:
The assistant's reply is broadly consistent with the ground truth: it correctly emphasizes that ischemic Charcot foot is managed differently (requiring revascularization combined with surgical/orthopedic treatment) and that this approach can lead to limb salvage. It appropriately calls for larger, prospective studies. However, the answer is repetitive, omits the key numeric outcomes from the study (90% limb salvage, mean healing time ~197 days), slightly overstates certainty by calling the available data "the only evidence," and includes extraneous/copyright text. Overall accurate but not concise or fully precise.

conciseness: 0.3
Reasoning:
The response is verbose and repetitive and only indirectly answers the question. It repeatedly states that ischemic Charcot foot "seems" different and that combined revascularization plus surgical/orthopedic treatment "can be" effective, but it fails to concisely summarize the study's concrete findings (90% limb salvage, mean healing time ~197 days) or directly state whether this represents a distinct entity requiring different treatment. It also contains irrelevant repetition and boilerplate about future studies and publisher copyright. Overall it is not concise or tightly focused on the question.

relevance: 0.6
Reasoning:
The assistant's reply is generally relevant: it directly answers that ischemic Charcot foot is managed differently and endorses the combined approach used in the study (endovascular revascularization plus surgical/orthopedic treatment). However, it does not quote or cite specific data from the provided context (no mention of the 10-patient series, 90% limb-salvage rate, 197-day mean healing time), and it adds unreferenced statements (e.g., "very rare") and repetitive calls for further study. Overall the response is appropriate in conclusion but weak on grounding in the actual quoted results and specific evidence.

coherence: 0.6
Reasoning:
The response is broadly coherent and stays on-topic: it answers the question by asserting that ischemic Charcot foot requires a different treatment approach and recommends combined endovascular revascularization, surgical debridement, and orthopedic correction. Strengths include clear conclusions and sensible calls for larger, prospective/multicenter studies. Weaknesses: the text is repetitive and partly duplicated, contains an irrelevant copyright line, and fails to cite or summarize the study’s concrete outcome data (e.g., 90% limb salvage, mean healing time ~197 days). It also slightly overstates certainty (“only evidence available”) despite acknowledging the need for further study.

helpfulness: 0.6
Reasoning:
The assistant's reply correctly conveys the study's main takeaways — that ischemic Charcot foot is managed differently (combining endovascular revascularization, surgical debridement, and orthopedic correction) and that this approach can avoid major amputation — and appropriately calls for larger, prospective studies. However, the answer is repetitive, lacks key study details (e.g., the 90% limb salvage rate and mean healing time ~197 days), does not clearly state that revascularization is necessary to enable surgical/orthopedic treatment, and includes irrelevant/publisher boilerplate. Overall it is broadly helpful but incomplete and somewhat poorly edited.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: The current study showed that RH does not improve survival outcomes compared to mRH or SH in patients with suspected cervical involvement. However, we cannot exclude the possibility of a beneficial effect of RH on survival due to the small number of patients. Although there were more complications after RH than other procedures, this should be considered in the context of individual patient's condition. Further prospective randomized trials are required to elucidate the role of RH for cervical involvement. The long-term benefit of RH over mRH or SH remains unknown. We also need to investigate the optimal timing for postoperative adjuvant therapy. Furthermore, the current study did not include data on ovarian function, which is an important issue in young women. In addition, further investigation is warranted to clarify whether RH improves survival in patients with cervical involvement. Finally, the current study could not exclude the possibility that RH might have a positive effect on survival if the tumor size was greater than 5 cm or involved the cervix and/or parametria. Therefore, RH may be appropriate for some patients with suspected cervical involvement. In contrast, SH may be preferred for patients with limited tumors without clear evidence of invasion. The choice of surgery depends on each institution's experience and preferences. However, a randomized controlled trial would be necessary to confirm our findings. To address these issues, a large-scale multicenter randomized controlled trial is essential. The Gynecologic Oncology Trial and Investigation Consortium of North Kanto will launch this study shortly. This trial will be conducted at seven institutions across Japan. Patients will be randomly assigned to either RH or mRH based on the current standard treatment. In addition, a new group of patients will receive SH. The primary endpoint will be OS, and secondary endpoints will be PFS and safety. This trial will provide us with valuable information regarding the best surgical approach for patients with suspected cervical involvement. Until then, the current study results will serve as the basis for future studies. Our study demonstrated that RH is not superior to mRH or SH for patients with suspected cervical involvement. It is important to note that the current study included only Japanese patients. Future studies need to be performed to determine whether the results are applicable to Western populations.
Keywords: Endometrial cancer; Cervical involvement; Radical hysterectomy; Modified radical hysterectomy; Simple hysterectomy; Survival outcome; Progression-free survival.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.3
Reasoning:
The assistant's answer correctly states the study's main findings that radical hysterectomy (RH) did not show a survival benefit compared with modified radical or simple hysterectomy and that RH had higher perioperative/late morbidity. It appropriately calls for prospective randomized study for confirmation. However, the reply adds several unsupported or speculative claims: (1) it emphasizes a small-sample limitation that is not reported as a primary reason the study could not show benefit (the cohort was 300 patients), (2) it invents details about an upcoming randomized trial (that GOTIC will "launch this study shortly" with specific arms and endpoints) that are not in the provided study text, and (3) it raises subgroup hypotheses (tumor >5 cm, ovarian function issues) and practice recommendations beyond the data without clear basis. The response is also repetitive. Because it mixes correct summary points with multiple unsupported fabrications and unwarranted speculation, its overall reliability is limited.

conciseness: 0.3
Reasoning:
The response states the main finding (RH did not improve survival versus mRH or SH) but is verbose, repetitive, and includes several speculative or extraneous points (e.g., unverified trial launch, repeated calls for RCTs, details about ovarian function and tumor size) that do not concisely address the question. It could be much shorter: a one- or two-sentence summary of the study conclusions and key adverse-event findings would suffice.

relevance: 0.5
Reasoning:
The assistant's reply is partially relevant: it correctly states the main findings reported in the context (no survival benefit of radical hysterectomy [RH] versus modified or simple hysterectomy, and higher complication rates with RH). However, the response adds multiple speculative or unsupported claims not present in the provided context (e.g., small sample-size caveat as a primary limitation, lack of ovarian-function data, tumor-size >5 cm subgroup benefit, that GOTIC will imminently launch a large randomized trial with specific arms). It also repeats points redundantly and makes recommendations beyond the study's actual retrospective findings. Overall, the answer addresses the question but includes inaccurate or unsupported extrapolations and unnecessary detail.

coherence: 0.6
Reasoning:
Explanation: The assistant's answer is generally coherent and organized: it states the main finding (no survival benefit of RH), notes increased complications after RH, and calls for prospective randomized trials. However the response is repetitive, includes several speculative or unsupported details (e.g., planned multicenter randomized trial by GOTIC, subgroup claims about tumor size >5 cm and ovarian function not assessed) that were not reported in the ground truth, and adds points beyond the study results without clear attribution. Overall it communicates the study's conclusions but suffers from redundancy and some unverifiable assertions.

helpfulness: 0.6
Reasoning:
The assistant's answer correctly captures the study's main conclusion (radical hysterectomy [RH] did not show a survival benefit and was associated with more complications) and appropriately calls for prospective randomized study. However, it includes several unsupported or speculative claims (e.g., that GOTIC will shortly launch a specific multicenter randomized trial with three arms, assertions about tumor-size >5 cm effects, and that the study omitted ovarian-function data) that are not in the presented ground truth. The response is also repetitive, sometimes framed from the authors' voice ("we"), and lacks specific data (no numbers, effect sizes, or p-values) that would make the summary more precise and useful.

Strengths:
- Accurately states the main finding (no survival benefit for RH).
- Notes higher complication rates with RH and the need for prospective trials.

Weaknesses:
- Adds speculative future-trial details and other claims not supported by the provided study summary.
- Repetitive and somewhat disorganized.
- Omits quantitative results and key statistical details available in the study summary (e.g., that hysterectomy type was not an independent prognostic factor in multivariate analysis).

Overall this is a moderately helpful but imperfect summary.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Readmissions after PD occur frequently and are influenced by various factors. Future efforts should be directed toward improving patient outcomes through better perioperative care, particularly during the initial phase after PD. The use of prophylactic antibiotics, early mobilization, and prompt management of complications may reduce the rate of readmissions. Moreover, a detailed understanding of the reasons for readmission could help identify areas where improvement in quality of care might be possible. Our results suggest that readmissions after PD are multifactorial and require a comprehensive approach to address them effectively. Further studies using large datasets are needed to validate these findings. These will help us develop evidence-based guidelines for prevention of readmissions after PD. This work was supported by the National Institutes of Health Grant UL1 RR024156. The authors report no financial or other conflicts of interest related to this work. Copyright © 2016 American Society of Anesthesiologists Inc. Published by Elsevier Inc. All rights reserved.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.3
Reasoning:
The assistant's reply is too general and misses the study's key, specific findings. The response fails to state that pancreatic fistula and complexity of the initial resection (multivisceral resection) were independently associated with readmission, and it does not note that half of readmissions occur within 7 days — a crucial point leading to the recommendation to focus on preventing early readmissions. Instead, it offers generic perioperative measures (antibiotics, mobilization) not directly derived from the reported predictors, and it includes unrelated boilerplate (funding/conflict/copyright) that was not part of an answer. Overall the reply does not accurately or sufficiently convey the study's main conclusions or practical implications.

conciseness: 0.3
Reasoning:
The response is vague and misses the key, concise findings from the study: it does not mention that pancreatic fistula and more complex (multivisceral) initial resections were independently associated with readmission, nor that half of readmissions occur within 7 days and thus prevention should focus on early postdischarge period. Instead it offers generic suggestions (antibiotics, mobilization) and includes irrelevant funding/copyright text. Overall it is not a concise, targeted summary of the study's main conclusions.

relevance: 0.4
Reasoning:
The assistant's reply addresses the general question of preventing readmissions after PD by recommending perioperative improvements and better complication management, so it is partly relevant. However, it fails to cite or reference the specific, real findings from the provided context (notably that pancreatic fistula and complexity of initial resection/multivisceral resection were independent predictors of readmission, and that ~50% of readmissions occur within 7 days). Instead it offers generic preventive measures and includes unrelated publication boilerplate. Because it does not refer to the key, real quotes/findings from the context, its relevance to the specific question is limited.

coherence: 0.3
Reasoning:
The assistant's reply is coherent and organized but overly generic and not well grounded in the study data. It fails to highlight the study's key, actionable findings — that pancreatic fistula and more complex resections (multivisceral procedures, prolonged initial stay, ICU admission) were independent predictors of readmission, and that half of readmissions occur within 7 days with different early vs late causes — which would imply focusing prevention efforts on early postoperative complications and on reducing fistula/complexity-related problems. It also includes irrelevant boilerplate (funding/copyright) and suggests interventions (e.g., prophylactic antibiotics) not supported or discussed by the presented results.

helpfulness: 0.3
Reasoning:
The assistant's reply is generic and only partially helpful. It suggests broad perioperative measures but fails to report or use the study's specific findings: that pancreatic fistula and complex/multivisceral resections were independent predictors of readmission, and that about 50% of readmissions occur within 7 days (early readmissions) with different causes than later readmissions. Because it omits those key, actionable insights (and even includes irrelevant publication/copyright text), it does not adequately answer the question about whether readmissions after PD can be prevented or how to target prevention efforts (especially early readmissions).

================================================================================
Average correctness Score: 0.43
Average conciseness Score: 0.305
Average relevance Score: 0.5
Average coherence Score: 0.475
Average helpfulness Score: 0.435
